Dapagliflozin Lowers HbA1c, Systolic Blood Pressure and Serum Uric Acid in Patients With Type 2 Diabetes and Hypertension, Regardless of Class of Concomitant Antihypertensive Therapy

被引：0
|
作者：
Weber, Michael A.
Mansfield, Traci A.
Iqbal, Nayyar
Parikh, Shamik J.
Ptaszynska, Agata
机构：
来源：
CIRCULATION | 2014年 / 130卷
关键词：
Diabetes (Type II); Antihypertensive agents; Blood pressure; Hypertension; Glucose;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
13640
引用
收藏
页数：3
相关论文
共 50 条
  • [41] HbA1c, Blood Pressure, and Cholesterol (ABC) Control in Patients with Type 2 Diabetes from Tibet in China
    Zhang Chenghui
    Li Mingxia
    Wang Suyuan
    Wu Yunhong
    DIABETES, 2019, 68
  • [42] Effects of canagliflozin on body weight and relationship to HbA1c and blood pressure changes in patients with type 2 diabetes
    William T. Cefalu
    Kaj Stenlöf
    Lawrence A. Leiter
    John P. H. Wilding
    Lawrence Blonde
    David Polidori
    John Xie
    Daniel Sullivan
    Keith Usiskin
    William Canovatchel
    Gary Meininger
    Diabetologia, 2015, 58 : 1183 - 1187
  • [43] Effects of canagliflozin on body weight and relationship to HbA1c and blood pressure changes in patients with type 2 diabetes
    Cefalu, William T.
    Stenlof, Kaj
    Leiter, Lawrence A.
    Wilding, John P. H.
    Blonde, Lawrence
    Polidori, David
    Xie, John
    Sullivan, Daniel
    Usiskin, Keith
    Canovatchel, William
    Meininger, Gary
    DIABETOLOGIA, 2015, 58 (06) : 1183 - 1187
  • [44] A study to understand HbA1c, blood pressure, & lipid control (ABC) in patients with Type 2 Diabetes Mellitus
    Saxena, A.
    Patil, A.
    Chandra, K. P.
    Gupta, M.
    Maheshwari, A.
    Dariya, S. S.
    Regulla, R.
    Singh, N. K.
    Meenakshisundaram, L. M.
    Kumar, D.
    Hiremath, V.
    Sheohare, R.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
  • [45] Effects of HbA1c and weight reduction on blood pressure in patients with type 2 diabetes mellitus treated with exenatide
    Paul, S.
    Best, J.
    Klein, K.
    Han, J.
    Maggs, D.
    DIABETES OBESITY & METABOLISM, 2012, 14 (09): : 826 - 834
  • [46] Add-on therapy with dapagliflozin in routine outpatient care of type 2 diabetes patients from Turkey: a retrospective cohort study on HbA1c, body weight, and blood pressure outcomes
    Ertugrul, Derun Taner
    Kan, Erdal
    Tura, Cigdem Bahadir
    Tugtekin, Haci Bayram
    Ayakta, Hayati
    Celebioglu, Mehmet
    Yilmaz, Ceren
    Utebay, Onur
    Yetkin, Ilhan
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2022, 42 (01) : 147 - 160
  • [47] Add-on therapy with dapagliflozin in routine outpatient care of type 2 diabetes patients from Turkey: a retrospective cohort study on HbA1c, body weight, and blood pressure outcomes
    Derun Taner Ertugrul
    Erdal Kan
    Cigdem Bahadir Tura
    Haci Bayram Tugtekin
    Hayati Ayakta
    Mehmet Celebioglu
    Ceren Yılmaz
    Onur Utebay
    Ilhan Yetkin
    International Journal of Diabetes in Developing Countries, 2022, 42 : 147 - 160
  • [48] Depressive symptoms and HbA1c in patients with Type 1 and Type 2 diabetes
    Kawada, T.
    DIABETIC MEDICINE, 2014, 31 (06) : 759 - 760
  • [49] THE IMPACT OF BASELINE HBA1C AND HBA1C TRAJECTORIES ON TIME TO THERAPY ESCALATION IN TYPE 2 DIABETES MELLITUS
    McEwan, P.
    Foos, V
    Larnotte, M.
    VALUE IN HEALTH, 2015, 18 (07) : A698 - A698
  • [50] Initiation of combination therapy in type 2 diabetes patients with high HbA1c at diagnosis
    Klok, R.
    Gulati, T.
    Rajpathak, S.
    Pal, S.
    Yang, L.
    Bandyopadhyay, A.
    Khunti, K.
    DIABETOLOGIA, 2019, 62 : S177 - S177
12345